1.140USD-0.87%Mkt Cap: 14.11M USDP/E: —Last update: 2026-06-01
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology pipeline includes HB-…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap14.11M USD
Enterprise Value-25.23M USD
Revenue (TTM)9.35M USD
Gross Profit-50.47M USD
Net Income (TTM)-43.50M USD
Revenue/Share0.7470 USD
Last Price1.140 USD
Fiscal Year EndDec 2024
MR QuarterMar 2025
Employees82
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.21
PEG—
EV/EBITDA0.35
EV/Revenue-2.70
P/S1.52
P/B0.42
EPS (TTM)-4.83
EPS (Forward)-5.43
52W Range
0.811039% of range1.650
52W High1.650 USD
52W Low0.8110 USD
Profitability
Gross Margin0.00%
Oper. Margin-885.28%
EBITDA Margin0.00%
Profit Margin-98.99%
ROE-84.94%
ROA-52.70%
Growth
Revenue Growth-94.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-76.98M USD
CapEx (TTM)194.00K USD
FCF Margin-350.89%
FCF Yield-232.55%
Net Debt-39.68M USD
Net Debt/EBITDA0.55
Balance Sheet
Debt/Equity0.02
Current Ratio3.61
Quick Ratio2.92
Book Value/Sh2.714 USD
Cash/Share3.178 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 10, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.98M
Float12.34M
Insiders0.13%
Institutions3.16%
Short Interest
Short Ratio0.6d
Short % Float0.45%
Short % Out.0.29%
Shares Short35.80K
Short (prev mo.)130.56K
Technical
SMA 501.138 (+0.1%)
SMA 2000.9810 (+16.2%)
Beta0.83
S&P 52W Chg27.94%
Avg Vol (30d)8.47K
Avg Vol (10d)9.83K
Technical Indicators
RSI (14)49.9
MACD-0.0018
MACD Signal0.0060
MACD Hist.-0.0079
BB Upper1.228 USD
BB Middle1.168 USD
BB Lower1.107 USD
BB Width10.33%
ATR (14)0.0438 USD
Vol Ratio (20d)0.28x